52 related articles for article (PubMed ID: 9657622)
21. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
Dahlöf B
Blood Press Suppl; 1994; 2():35-40. PubMed ID: 8061844
[TBL] [Abstract][Full Text] [Related]
23. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
Dahlöf B
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
[TBL] [Abstract][Full Text] [Related]
24. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
25. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
27. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Krauser DG; Devereux RB
Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
[TBL] [Abstract][Full Text] [Related]
28. Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.
Morisco C; Argenziano L; Tozzi N; Mele AF; Ricciardelli B; Condorelli G; Trimarco B
Drugs; 1993; 46 Suppl 2():88-94. PubMed ID: 7512489
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular hypertrophy--the problem and possible solutions.
Gosse P
J Int Med Res; 2005; 33 Suppl 1():3A-11A. PubMed ID: 16222895
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
Clement DL; De Buyzere M; Duprez D
Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
[TBL] [Abstract][Full Text] [Related]
31. Regression of left ventricular hypertrophy is a key goal of hypertension management.
Zhang R; Crump J; Reisin E
Curr Hypertens Rep; 2003 Aug; 5(4):301-8. PubMed ID: 12844464
[TBL] [Abstract][Full Text] [Related]
32. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy.
van Zwieten PA
Cardiovasc Res; 2000 Jan; 45(1):82-91. PubMed ID: 10728317
[TBL] [Abstract][Full Text] [Related]
33. Regression of left ventricular hypertrophy: are there preferred drugs?
Diamond JA; Phillips RA
Curr Hypertens Rep; 2003 Oct; 5(5):368-71. PubMed ID: 12948428
[TBL] [Abstract][Full Text] [Related]
34. The heart in the hypertensive elderly.
Grodzicki T; Messerli FH
J Hum Hypertens; 1998 Sep; 12(9):593-7. PubMed ID: 9783486
[TBL] [Abstract][Full Text] [Related]
35. Management of hypertension in patients with left ventricular hypertrophy.
Cuspidi C; Sala C; Zanchetti A
Curr Hypertens Rep; 2007 Dec; 9(6):498-505. PubMed ID: 18367014
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic advances in the treatment of left ventricular hypertrophy.
Natsume T
Eur Heart J; 1993 Jul; 14 Suppl D():33-7. PubMed ID: 8370375
[TBL] [Abstract][Full Text] [Related]
37. Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy.
Hansson L
Adv Exp Med Biol; 1997; 432():189-90. PubMed ID: 9433525
[TBL] [Abstract][Full Text] [Related]
38. Anti-hypertensive drugs have different effects on ventricular hypertrophy regression.
Ferreira Filho C; Abreu LC; Valenti VE; Ferreira M; Meneghini A; Silveira JA; Riera AR; Colombari E; Murad N; Santos-Silva PR; Silva LJ; Vanderlei LC; Carvalho TD; Ferreira C
Clinics (Sao Paulo); 2010 Jul; 65(7):723-8. PubMed ID: 20668631
[TBL] [Abstract][Full Text] [Related]
39. Effects of combination therapy on the heart.
Messerli FH; Michalewicz L
J Hum Hypertens; 1997 Jan; 11(1):29-33. PubMed ID: 9111154
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the cardiac effects of antihypertensive agents.
Agabiti-Rosei E
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S42-8. PubMed ID: 7609505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
